Dupont Jakob - Insider Non-Derivative Transactions at Pyxis Oncology, Inc. (PYXS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 26, 2024, Dupont Jakob's relationship to Pyxis Oncology, Inc. (PYXS) is Director, and currently has 38,741 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PYXS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Dupont Jakob - Insider Non-Derivative Transactions of PYXS Common Stock

Dupont Jakob - Insider Non-Derivative Transactions at PYXS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Mar 27, 2024	Acquisition -- (Common Stock)	38741	0	38741